Halofuginone treatment has been shown to reduce the serum Tg Ab levels and to decrease the number of Th17 cells in the NOD.H-2h4 mouse model of spontaneous autoimmune thyroiditis [69]. This evidence concerns the gene TG and autoimmune thyroid disease.